OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Endocrinology Diabetes and Obesity is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Utilizing type 2 diabetes medications outside glycemic parameters – where are we headed?	37
Maximizing diabetes education efforts in vulnerable populations – newer delivery concepts	34
Updates in thyroid healthcare delivery: advancing patient-centered care	32
Editorial: Health considerations across the lifespan for patients with polycystic ovary syndrome	31
The female athlete triad: review of current literature	30
Nutrition and thyroid disease	28
Advances in assessment and treatment of bone, mineral and parathyroid disorders	27
MR-based techniques for intracortical vessel visualization and characterization: understanding the impact of microvascular disease on skeletal health	26
Advances in the care of lipodystrophies	26
Editorial introduction	25
Editorial introduction	24
Editorial introductions	24
Detection strategies for elevated lipoprotein(a): will implementation let the genie out of the bottle?	23
Prevalence and correlates of androgen dependence: a meta-analysis, meta-regression analysis and qualitative synthesis	20
An update on bone in diabetes	20
Recent advances in anaplastic thyroid cancer management	20
Financial toxicity in thyroid cancer survivors	20
Preventing type 1 diabetes development and preserving beta-cell function	19
Update on fracture risk assessment in osteoporosis	17
The role for long-term use of dehydroepiandrosterone in adrenal insufficiency	17
Editorial introduction	16
Interactions between antidiabetes medications and heart–brain axis	15
Gastrointestinal hormones and regulation of gastric emptying	15
The use of anabolic agents in the treatment of osteoporosis: a clinical update	15
Targeting apolipoprotein C-III: a game changer for pancreatitis prevention in severe hypertriglyceridemia	14

Epidemiologic changes in thyroid disease	13
Bone marrow fibrocytes: villain or white knight in thyroid-associated ophthalmopathy?	13
Low-carbohydrate diets in type 1 diabetes: balancing benefits and risks	12
Fibrous dysplasia in children and its management	12
Long-acting amylin analogues for the management of obesity	12
Lipidomics in diabetes	11
Precision medicine in diabetes care	11
The uncommon forms of congenital adrenal hyperplasia	11
Assisted reproductive technology outcomes and management considerations for people with epilepsy	11
TSHR-IGF-IR complex drives orbital fibroblast misbehavior in thyroid eye disease	11
New perspectives on the high-density lipoprotein system and its role in the prevention and treatment of atherosclerotic cardiovascular disease	11
Growth and development in type 1 diabetes	11
A short history of saturated fat: the making and unmaking of a scientific consensus	10
Recent advances in fibroblast growth factor 23-related hypophosphatemic disorders	10
Type 2 diabetes: a contemporary view from the Asian lens	10
Editorial introductions	10
Glucocorticoid withdrawal syndrome: what to expect and how to manage	10
An update on investigation and management of renal bone disease	9
Adrenal insufficiency and pregnancy	9
Legislation, medicine, and politics: care for gender diverse youth	9
Induction of antigenic immune tolerance to delay type 1 diabetes – challenges for clinical translation	9
Novel techniques for assessment of bone tissue material properties	9
Editorial introductions	9
Short-term hyper-caloric high-fat feeding on a ketogenic diet can lower low-density lipoprotein cholesterol: the cholesterol drop experiment	9
The interaction between gut microbiome and bone health	8
Early anthropometric indicators of type 2 diabetes mellitus	8
Time to cycle regularity and health risks	8
Multifactorial chylomicronemia syndrome	8
An Update on Vitamin D Deficiency in the twenty-first century: nature and nurture	8
Indications for testosterone therapy in men	8
Editorial introductions	8
Self-antigens, benign autoimmunity and type 1 diabetes: a beta-cell and T-cell perspective	7
Treating obesity in type 1 diabetes mellitus – review of efficacy and safety	7
Microplastics, cardiometabolic risk, genetics and Alzheimer's disease	7
Advanced imaging and theranostics in thyroid cancer	7
Continuous glucose monitoring in primary care – are we there?	7
Type 2 diabetes mellitus and cognitive function: understanding the connections	7
HDL functionality in type 1 and type 2 diabetes: new insights	6
Gestational diabetes and other adverse pregnancy outcomes in polycystic ovary syndrome	6
The 1 mg overnight dexamethasone suppression test: a danger to the adrenal gland?	6
Testosterone and the prevention of type 2 diabetes mellitus: therapeutic implications from recent trials	6
Current challenges in Cushing's syndrome testing: blood, saliva, urine, or hair?	6
Polygenic risk scores for the diagnosis and management of dyslipidemia	6
Radiofrequency ablation (RFA) compared to observation for benign thyroid nodules: emerging considerations for judicious use	6
The psychosocial impact of thyroid cancer	6
Assessing the contribution of plastic-associated obesogenic compounds to cardiometabolic diseases	6
Bridging the LatinX community care gap	5
Skeletal health in diabetes	5
Editorial: New horizons for thyroid diseases: transformative changes and tailored care	5
When history, law, and medicine intersect	5

Gastrointestinal regulatory peptides	5
Recent advances in the role of miRNAs in bone disease	5
Editorial introductions	5
Predictors of cardiovascular risk in familial hypercholesterolemia	5
Fracture prediction tools in diabetes	5
Preconception health optimization in women with polycystic ovary syndrome − how to find the time?	4
Glutamic acid decarboxylase immunotherapy for type 1 diabetes	4
Utilizing point-of-care A1c to impact outcomes – can we make it happen in primary care?	4
Subclinical hyperthyroidism	4
Body composition in sexual precocity	4
Prediabetes and skeletal health	4
The approaches and challenges in the management of differentiated thyroid carcinoma	4
Bone marrow adiposity in diabetes and clinical interventions	4
Growth and development in monogenic forms of neonatal diabetes	4
Potassium-competitive acid blockers and acid-related disorders	4
Mixed-methods research on androgen abuse – a review	4
Cardiometabolic risk and therapeutic outcomes in mild autonomous cortisol secretion	4
Hypoparathyroidism update	4
Differences in the management of thyroid nodules in children and adolescents as compared to adults	3
Adjunctive diabetes therapies and cardiovascular protection in type 1 diabetes: tackling the challenging Tchaikovsky piece	3
Overview of diabetes agents in cardiovascular disease: it takes an orchestra to play Tchaikovsky in symphony	3
Better care for women with polycystic ovary syndrome – a proposal for an international evidence based best practice framework to improve care	3
Update on management of paediatric dyslipidaemia	3
An update: maternal iodine supplementation, thyroid function tests, and child neurodevelopmental outcomes	3
Glucagon-like peptide-1 receptor agonists and safety in the preconception period	3
Enteroendocrine cell differentiation and function in the intestine	3
Cardiovascular disease in metabolic-associated fatty liver disease	3
Editorial introductions	3
Obesity during pregnancy: contemporary evidence and clinical implications	3
Use of anti-Müllerian hormone for understanding ovulatory dysfunction in polycystic ovarian syndrome	3
Health effects of androgen abuse: a review of the HAARLEM study	3
Emerging treatment for congenital adrenal hyperplasia	3
Biomarkers in gastroenteropancreatic neuroendocrine neoplasms	3
Editorial: Childhood endocrine and genetic disorders: improving adult outcomes	3
Coronary artery event-free or resilient familial hypercholesterolemia: what's in a name?	3
Can remnant cholesterol (triglyceride-rich lipoproteins) reclassify estimated risk of atherosclerotic cardiovascular disease?	2
Current perspectives on biomarkers in metabolic bone disease	2
Use of calculated free testosterone in men: advantages and limitations	2
Adherence to pharmacotherapy: sine qua non for reducing cumulative risk of premature coronary disease in familial hypercholesterolemia	2
Editorial introduction	2
Editorial overview	2
Editorial introductions	2
Editorial introduction	2
Mouse models of type 1 diabetes and their use in skeletal research	2
Eicosapentaenoic acid vs. docosahexaenoic acid for the prevention of cardiovascular disease	2
Effect of incretins on skeletal health	2
Addressing genetic and environmental sources of cardiometabolic disease	2
Molecular tools for diagnosing diseases of the adrenal cortex	2
Under and overtreatment with thyroid hormone replacement during pregnancy	2
Emerging concepts in the diagnosis and management of metabolically associated steatotic liver disease	2
Obesity-related glomerulopathy: a lesser known complication of obesity	2
Selective progesterone receptor modulators and reproductive health	2
Benefits and risks of apps for patients	2
Molecular testing for indeterminate thyroid nodules: past, present, and future	2
Editorial introductions	2
An overview of persistent chylomicronemia: much more than meets the eye	2